Serialization, labeling & track-and-trace

01Overview and value chain

Markers: [EC: US DSCSA, EU FMD & China 2D-code mandate (GS1 Data Matrix) | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)]

Serialization, labeling and track-and-trace is the equipment and software layer that assigns a unique, machine-readable identity — typically a GS1 2D Data Matrix code — to every saleable unit of a pharmaceutical product, prints and verifies it on the packaging line, aggregates child-to-parent relationships (bottle into bundle into case into pallet), and then follows each unit electronically from factory to dispenser through a multi-enterprise network. It is the regulatory backbone of the US Drug Supply Chain Security Act (DSCSA, full traceability from 2023), the EU Falsified Medicines Directive (FMD, with the European Medicines Verification System and on-pack anti-tamper seals) and China’s two-dimensional-code mandate, and the operational foundation of anti-counterfeiting, targeted recall and chargeback-verification workflows. The platform is mid-transformation along four axes: the move from lot-level to unit-level traceability as DSCSA phase-in completes; cloud multi-enterprise networks (TraceLink OPUS) replacing point-to-point data exchange; agentic AI orchestration of supply-chain workflows; and integration of serialization with primary-packaging inspection (Antares Vision’s packaging-line ecosystem shown at Interpack 2026).

The key directions of serialization and track-and-trace are:

1. Multi-enterprise serialization networks (TraceLink OPUS): cloud platforms that orchestrate serial-number allocation, verification and exception handling across contract manufacturers, brand owners, distributors and dispensers on a single network rather than point-to-point EDI.
2. Integrated packaging-line serialization (Antares Vision, Uhlmann): vision-based camera inspection plus 2D-code printing and aggregation built into blister and bottle lines, turning packaging into a central node for inspection, traceability and authentication.
3. End-to-end supply-chain traceability (OPTEL): track-and-trace platforms spanning factory serialization through distribution to point-of-dispense verification, often extended to cold-chain and specialty-pharma chain-of-identity and chain-of-custody.
4. Regulatory-mandate compliance (DSCSA, FMD, China code): serialization stacks engineered against the specific requirements of the US DSCSA tractable-package law, the EU FMD/EMVS and China’s National Medical Products Administration 2D-code mandate.

Sectoral value chain

[serial number allocation] ──> [2D-code print & vision verify] ──> [aggregation (bottle→bundle→case→pallet)]
                                            │
                                  (multi-enterprise network upload)
                                            │
                                            ▼
[dispenser verification] <─── [distribution scanning] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Pharma serialization (Pharma Serialization): GS1 2D Data Matrix identity stamped on every saleable unit, the foundation of unit-level traceability.
• Supply-chain track-and-trace (Supply-Chain Track-and-Trace): end-to-end electronic follow of each serialized unit through aggregation and verification.

02US

The United States is the largest single market for serialization and track-and-trace, driven by the DSCSA’s transition to unit-level traceability, and is home to the leading multi-enterprise serialization network (TraceLink). DSCSA compliance — including the 2023 package-level tracing requirement — is the regulatory engine pulling unit-level serialization across every pharma supply-chain actor.

DSCSA unit-level tracing, multi-enterprise network, FDA compliance

• TraceLink — OPUS platform: the largest pharma multi-enterprise serialization network, with agentic AI orchestration of supply-chain workflows across contract manufacturers, brand owners, distributors and dispensers.
• FDA DSCSA: the US tractable-package law requiring package-level serialization, aggregation and tracing across the supply chain.
• US specialty-pharma chain-of-custody: cold-chain and specialty-pharma track-and-trace extensions tying temperature events to serialized identity.

03CN

China is a demanding serialization market under the National Medical Products Administration’s two-dimensional-code mandate, which requires a unique traceable 2D code on every saleable drug unit. Domestic pharmaceutical manufacturers, contract packagers and distributors run serialization stacks against the NMPA mandate, but the dedicated serialization-OEM layer remains substantially imported (Italian, German and North-American), so the Chinese regional block is held qualitative.

NMPA 2D-code mandate, domestic pharma adoption, imported OEM base

• NMPA two-dimensional-code mandate: requires a unique traceable 2D code on every saleable drug unit, with national verification-system upload.
• Domestic pharmaceutical adoption: manufacturers, contract packagers and distributors run serialization stacks against the NMPA mandate, with localized label-printing and line-integration services.
• Imported OEM base: the dedicated serialization-OEM layer (vision-inspection cameras, aggregation software, multi-enterprise networks) is predominantly imported; domestic firms localize integration and label printing rather than the serialization platform itself.

04EU

Europe is the centre of the packaging-line serialization-OEM class: Antares Vision (Brescia, Italy, founded 1989, including Systech International), Uhlmann Pac Systeme (Laupheim, Germany, founded 1948) and SEA Vision (Concorezzo, Italy) build the vision-inspection, printing and aggregation systems integrated into European blister and bottle lines, and the EU Falsified Medicines Directive — through the European Medicines Verification System — defines the verification bar.

packaging-line OEMs, FMD/EMVS verification, Italian-German cluster

• Antares Vision Group: integrated serialization, vision inspection and traceability ecosystem (incl. Systech International), showcased across Life Sciences at Interpack 2026.
• Uhlmann — Pac Systeme: blister and bottle packaging lines with integrated serialization, printing and aggregation.
• SEA Vision: SEAVISION serialization platform for pharmaceutical packaging lines.
• EU FMD & EMVS: the Falsified Medicines Directive and European Medicines Verification System defining on-pack anti-tamper and 2D-code verification at dispense.

05Leading companies and research institutes

06Tech stack and innovations

The stack combines line-side vision and printing, aggregation logic, a multi-enterprise network and regulatory verification hubs into one end-to-end traceable chain.

1. Line-side vision & printing (Line-Side Vision & Printing):
   • inkjet or laser print of the GS1 2D Data Matrix on every bottle, blister or case;
   • camera-based vision inspection verifying code grade, readability and data content at line speed.
2. Aggregation logic (Aggregation Logic):
   • parent-child hierarchy capture (bottle into bundle into case into pallet) by scanning at each packing station;
   • aggregation data uploaded to the multi-enterprise network for downstream chain-of-custody.
3. Multi-enterprise network (Multi-Enterprise Network):
   • cloud platforms (TraceLink OPUS) orchestrating serial allocation, verification and exception handling across contract manufacturers, brand owners, distributors and dispensers;
   • agentic AI orchestration of supply-chain workflows replacing point-to-point EDI.
4. Regulatory verification hubs (Regulatory Verification Hubs):
   • national verification systems (EU EMVS, NMPA hub, DSCSA-authorized trading-partner data) checking every serialized unit at dispense or sale.

07Value chains and production pipelines

Industrial pipeline of a serialized pharmaceutical packaging line (DSCSA / FMD / NMPA)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Serial number alloc.   │ ───> │ 2. Print & vision verify  │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Network upload         │ <─── │ 3. Aggregation            │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Distribution scanning  │ ───> │ 6. Dispenser verification │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Serial number allocation

The multi-enterprise network (TraceLink OPUS) or local site system allocates a pool of unique GS1 serial numbers to the production order, drawn from the brand-owner’s range.

Stage 2: Print and vision verify

Each bottle, blister or case is inkjet- or laser-printed with its 2D Data Matrix, then camera-inspected for code grade, readability and data content at line speed; rejects are ejected before aggregation.

Stage 3: Aggregation

Parent-child relationships (bottle into bundle, bundle into case, case into pallet) are captured by scanning at each packing station, building the full hierarchy needed for downstream tracing.

Stage 4: Network upload

Serialization and aggregation data are pushed to the multi-enterprise network, making pack-level identity and hierarchy available to every authorized trading partner in real time.

Stage 5: Distribution scanning

Wholesalers and distributors scan the 2D code at each receipt and shipment, maintaining chain-of-custody and flagging any orphan, duplicate or mismatched serial against the network.

Stage 6: Dispenser verification

The pharmacy or hospital scans the 2D code at dispense against the national verification system (EU EMVS, NMPA hub, DSCSA trading-partner data), which confirms or declines the pack before it reaches the patient.